These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38810268)

  • 41. Two-stage bottom-up tiered approach combining several alternatives for identification of eye irritation potential of chemicals including insoluble or volatile substances.
    Hayashi K; Mori T; Abo T; Ooshima K; Hayashi T; Komano T; Takahashi Y; Sakaguchi H; Takatsu A; Nishiyama N
    Toxicol In Vitro; 2012 Oct; 26(7):1199-208. PubMed ID: 22743076
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exploration and comparison of in vitro eye irritation tests with the ISO standard in vivo rabbit test for the evaluation of the ocular irritancy of contact lenses.
    Yun JW; Hailian Q; Na Y; Kang BC; Yoon JH; Cho EY; Lee M; Kim DE; Bae S; Seok SH; Lim KM
    Toxicol In Vitro; 2016 Dec; 37():79-87. PubMed ID: 27596521
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Validating and troubleshooting ocular in vitro toxicology tests.
    Barile FA
    J Pharmacol Toxicol Methods; 2010; 61(2):136-45. PubMed ID: 20096797
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative study of the ocular irritation potential of various alkyl polyglucoside surfactants.
    Cho SA; Han JH; An S; Lee KH; Park JH; Kim HK; Lee TR
    Cutan Ocul Toxicol; 2010 Mar; 29(1):50-6. PubMed ID: 20039788
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Opacity of bovine cornea in vitro induced by surfactants and industrial chemicals compared with ocular irritancy in vivo.
    Muir CK
    Toxicol Lett; 1985; 24(2-3):157-62. PubMed ID: 3983968
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Confirmation of in vitro and clinical safety assessment of behentrimonium chloride-containing leave-on body lotions using post-marketing adverse event data.
    Cameron DM; Donahue DA; Costin GE; Kaufman LE; Avalos J; Downey ME; Billhimer WL; Gilpin S; Wilt N; Simion FA
    Toxicol In Vitro; 2013 Dec; 27(8):2203-12. PubMed ID: 24064305
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the bovine corneal opacity-permeability assay as an in vitro alternative to the Draize eye irritation test.
    Vanparys P; Deknudt G; Sysmans M; Teuns G; Coussement W; Van Cauteren H
    Toxicol In Vitro; 1993 Jul; 7(4):471-6. PubMed ID: 20732236
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of a defined approach for eye irritation or serious eye damage for neat liquids based on cosmetics Europe analysis of in vitro RhCE and BCOP test methods.
    Alépée N; Adriaens E; Abo T; Bagley D; Desprez B; Hibatallah J; Mewes K; Pfannenbecker U; Sala À; Van Rompay AR; Verstraelen S; McNamee P
    Toxicol In Vitro; 2019 Sep; 59():100-114. PubMed ID: 30981694
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overall performance of Bovine Corneal Opacity and Permeability (BCOP) Laser Light-Based Opacitometer (LLBO) test method with regard to solid and liquid chemicals testing.
    Adriaens E; Verstraelen S; Desprez B; Alépée N; Abo T; Bagley D; Hibatallah J; Mewes KR; Pfannenbecker U; Van Rompay AR
    Toxicol In Vitro; 2021 Feb; 70():105044. PubMed ID: 33130054
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reprint of "CON4EI: Bovine Corneal Opacity and Permeability (BCOP) test for hazard identification and labelling of eye irritating chemicals".
    Verstraelen S; Maglennon G; Hollanders K; Boonen F; Adriaens E; Alépée N; Drzewiecka A; Gruszka K; Kandarova H; Willoughby JA; Guest R; Schofield J; Van Rompay AR
    Toxicol In Vitro; 2018 Jun; 49():53-64. PubMed ID: 29598995
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optimized rinsing procedures for enhancing removal of residues of highly viscous and colored substances in the Bovine Corneal Opacity and Permeability (BCOP) assay.
    Plodíková P; Pouzar M; Rösslerová Z; Prokopcová J
    Toxicol In Vitro; 2015 Oct; 29(7):1385-91. PubMed ID: 26028145
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Advancing ocular safety research: A comprehensive examination of benzocaine acute exposure without animal testing.
    Lenze M; Benedetti MD; Roco J; Ramírez PG; Blanco R; Yaceszen S; Corrales C; Wikinski S; Gutiérrez ML
    Toxicol Lett; 2024 Apr; 394():138-145. PubMed ID: 38458340
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Brinzolamide-loaded nanoemulsions: ex vivo transcorneal permeation, cell viability and ocular irritation tests.
    Mahboobian MM; Seyfoddin A; Aboofazeli R; Foroutan SM; Rupenthal ID
    Pharm Dev Technol; 2019 Jun; 24(5):600-606. PubMed ID: 30472913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro methods: their relevance and complementarity in ocular safety assessment.
    Rougier A; Cottin M; de Silva O; Roguet R; Catroux P; Toufic A; Dossou KG
    Lens Eye Toxic Res; 1992; 9(3-4):229-45. PubMed ID: 1301783
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathology of ocular irritation with bleaching agents in the rabbit low-volume eye test.
    Maurer JK; Molai A; Parker RD; Li L; Carr GJ; Petroll WM; Cavanagh HD; Jester JV
    Toxicol Pathol; 2001; 29(3):308-19. PubMed ID: 11442017
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A redesigned corneal holder for the bovine cornea opacity and permeability assay that maintains normal corneal morphology.
    Ubels JL; Paauw JD; Casterton PL; Kool DJ
    Toxicol In Vitro; 2002 Oct; 16(5):621-8. PubMed ID: 12206829
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ocular irritation reversibility assessment for personal care products using a porcine corneal culture assay.
    Donahue DA; Avalos J; Kaufman LE; Simion FA; Cerven DR
    Toxicol In Vitro; 2011 Apr; 25(3):708-14. PubMed ID: 21172418
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extent of initial corneal injury as a basis for alternative eye irritation tests.
    Jester JV; Li L; Molai A; Maurer JK
    Toxicol In Vitro; 2001 Apr; 15(2):115-30. PubMed ID: 11287171
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An in vitro depth of injury prediction model for a histopathologic classification of EPA and GHS eye irritants.
    Lebrun S; Xie Y; Chavez S; Chan R; Jester JV
    Toxicol In Vitro; 2019 Dec; 61():104628. PubMed ID: 31419508
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Confocal microscopic characterization of initial corneal changes of surfactant-induced eye irritation in the rabbit.
    Maurer JK; Li HF; Petroll WM; Parker RD; Cavanagh HD; Jester JV
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):291-300. PubMed ID: 9144446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.